This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Tel Aviv University. Active years: 2024-2026.
Company Filing History:
Years Active: 2024-2026
Title: The Innovative Contributions of Daniel Nataf
Introduction
Daniel Nataf is a prominent inventor based in Tel Aviv, Israel. He has made significant contributions to the field of genetic engineering, particularly in the area of targeted gene insertion. His work has implications for immunotherapy and other medical applications.
Latest Patents
Daniel Nataf holds a patent for "Recombination activating gene (RAG) induced V(D)J gene targeting." This invention relates to methods for the targeted insertion of nucleic acid sequences into a target genomic locus of a mammalian cell. The methods utilize nucleic acid cassettes that include recognition signal sequences for the insertion process, which is mediated by RAG-catalyzed recombination. The invention also encompasses cassettes, vectors, vehicles, and cells that incorporate these cassettes, along with their compositions and uses in immunotherapy. He has 1 patent to his name.
Career Highlights
Daniel Nataf is affiliated with Tel Aviv University, where he conducts research and develops innovative solutions in genetic engineering. His work is recognized for its potential to advance therapeutic techniques in medicine.
Collaborations
He has collaborated with notable colleagues, including Adi Barzel and Carmel Pundak-Mintz, contributing to a dynamic research environment that fosters innovation.
Conclusion
Daniel Nataf's contributions to genetic engineering and immunotherapy highlight his role as a leading inventor in his field. His innovative patent demonstrates the potential for targeted gene insertion techniques to revolutionize medical treatments.